Korea Herald – BusinessMarkets
LG Chem eyes 2029 trials for personalized cancer vaccine
LG Chem said Wednesday it aims to begin clinical development of a personalized mRNA cancer vaccine in 2029, leveraging artificial intelligence to accelerate drug discovery and identify patients most likely to benefit from treatment. The Korean chemical and pharmaceutical company…